XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Debt
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt
7.
Debt

The Company’s debt obligations consist of the following (in millions):

 

 

March 31,
2023

 

 

December 31,
2022

 

EUR notes (in U.S. Dollars) under the 2021 Note Purchase Agreement

 

$

162.8

 

 

$

160.6

 

CHF notes (in U.S. Dollars) under the 2021 Note Purchase Agreement

 

 

328.1

 

 

 

325.1

 

CHF notes (in U.S. Dollars) under the 2019 Note Purchase Agreement

 

 

324.8

 

 

 

321.9

 

U.S. Dollar notes under the 2019 Term Loan Agreement

 

 

289.5

 

 

 

293.3

 

U.S. Dollar notes under the 2012 Note Purchase Agreement

 

 

100.0

 

 

 

100.0

 

Unamortized debt issuance costs

 

 

(1.6

)

 

 

(1.7

)

Other loans

 

 

5.1

 

 

 

5.9

 

Total notes and loans outstanding

 

 

1,208.7

 

 

 

1,205.1

 

Finance lease obligations

 

 

20.4

 

 

 

14.1

 

Total debt

 

 

1,229.1

 

 

 

1,219.2

 

Current portion of long-term debt and finance lease obligations

 

 

(120.1

)

 

 

(18.7

)

Total long-term debt, less current portion

 

$

1,109.0

 

 

$

1,200.5

 

The following is a summary of the maximum commitments and the net amounts available to the Company under the 2019 Revolving Credit Agreement and other lines of credit with various financial institutions located primarily in Germany and Switzerland that are unsecured and typically due upon demand with interest payable monthly, at March 31, 2023 (in millions):

 

 

Weighted
Average
Interest Rate

 

Total Amount
Committed by
Lenders

 

 

Outstanding
Borrowings

 

 

Outstanding
Letters of
Credit

 

 

Total
Amount
Available

 

2019 Credit Agreement

 

0.15%

 

$

600.0

 

 

$

 

 

$

0.3

 

 

$

599.7

 

Bank guarantees and working capital line

 

varies

 

 

141.9

 

 

 

 

 

 

141.9

 

 

 

 

Total revolving lines of credit

 

 

 

$

741.9

 

 

$

 

 

$

142.2

 

 

$

599.7

 

As of March 31, 2023, the Company was in compliance with the financial covenants of all debt agreements.

As of March 31, 2023, the Company had several cross-currency and interest rate swap agreements with a notional value of $144.8 million of U.S. dollar to Swiss Franc and a notional value of $244.8 million of U.S. dollar to Euro to hedge the variability in the movement of foreign currency exchange rates on portions of our Euro and Swiss Franc denominated net asset investments. These agreements qualify for hedge accounting and accordingly the changes in fair value of the derivative are recorded in other comprehensive income and remain in accumulated comprehensive income (loss) attributable to Bruker Corporation in shareholders’ equity until the sale or substantial liquidation of the foreign operation. The difference between the interest rate received and paid under the interest rate and cross-currency swap agreements is recorded in interest and other income (expense), net in the consolidated statements of income and comprehensive income. The Company presents the cross-currency swap periodic settlements in investing activities and the interest rate swap periodic settlements in operating activities in the statement of cash flows.

On September 30, 2022, the Company entered into the Second Amendment to the 2019 Term Loan Agreement and the Second Amendment to the 2019 Credit Agreement (collectively, the "Amendments"), to modify certain aspects of the 2019 Term Loan Agreement and 2019 Credit Agreement, respectively. The Amendments modify the reference rate thereunder from London Interbank Offered Rate ("LIBOR") to Secured Overnight Financing Rate ("SOFR"). There were no other changes to the 2019 Term Loan Agreement or 2019 Credit Agreement as a result of the Amendments. The Company did not record any gains or losses on the conversion of the reference rate for borrowings under the Term Loan Agreement from LIBOR to SOFR.

On June 16, 2022, the Company entered into the First Amendment to the 2019 Credit Agreement to modify certain contract definitions within the agreement. Primarily, the current LIBOR rates were changed to new alternative base rates for the respective currencies. As part of the change any related items, such as fall-back rates and day conventions were also changed. No other material terms were modified with this agreement. During 2022, the Company adopted the practical expedient for Reference Rate Reform related to its debt arrangements and as such, this amendment is treated as a continuation of the existing debt agreement and no gain or loss on the modification was recorded.